111 related articles for article (PubMed ID: 32598254)
1. Analysis of the Differences in the Expression of mRNAs and miRNAs Associated with Drug Resistance in Endometrial Cancer Cells Treated with Salinomycin.
Januszyk P; Januszyk K; Wierzbik-Strońska M; Boroń D; Grabarek B
Curr Pharm Biotechnol; 2021; 22(4):541-548. PubMed ID: 32598254
[TBL] [Abstract][Full Text] [Related]
2. Salinomycin Modulates the Expression of mRNAs and miRNAs Related to Stemness in Endometrial Cancer.
Talkowski K; Kiełbasiński K; Peszek W; Grabarek BO; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2021; 22(2):317-326. PubMed ID: 32564748
[TBL] [Abstract][Full Text] [Related]
3. The Influence of Salinomycin on the Expression Profile of mRNAs Encoding Selected Caspases and MiRNAs Regulating their Expression in Endometrial Cancer Cell Line.
Januszyk K; Januszyk P; Grabarek BO; Boroñ D; Oplawski M
Curr Pharm Biotechnol; 2020; 21(14):1505-1515. PubMed ID: 32407273
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Variances in VEGF-A-D and VEGFR-1-3 Expression in the Ishikawa Endometrial Cancer Cell Line Treated with Salinomycin and Anti-Angiogenic/Lymphangiogenic Effect.
Kras P; Talkowski K; Grabarek BO; Skalska-Dziobek N; Boroń D; Oplawski M
Curr Pharm Biotechnol; 2021; 22(5):697-705. PubMed ID: 32648839
[TBL] [Abstract][Full Text] [Related]
5. Effect of Salinomycin on Expression Pattern of Genes Associated with Apoptosis in Endometrial Cancer Cell Line.
Kiełbasiński K; Peszek W; Grabarek BO; Boroń D; Wierzbik-Strońska M; Oplawski M
Curr Pharm Biotechnol; 2020; 21(12):1269-1277. PubMed ID: 32400328
[TBL] [Abstract][Full Text] [Related]
6. Variances in the Expression Profile of the EMT-Related Genes in Endometrial Cancer Lines In Vitro Study.
Nowakowski R; Grabarek B; Burnat-Olech A; Boroń D; Paul-Samojedny M
Curr Pharm Biotechnol; 2022; 23(4):594-608. PubMed ID: 34225617
[TBL] [Abstract][Full Text] [Related]
7. Expression Profile of mRNAs and miRNAs Related to the Oxidative-Stress Phenomenon in the Ishikawa Cell Line Treated Either Cisplatin or Salinomycin.
Januszyk S; Mieszczański P; Lurka H; Sagan D; Boroń D; Grabarek BO
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625926
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells.
Kusunoki S; Kato K; Tabu K; Inagaki T; Okabe H; Kaneda H; Suga S; Terao Y; Taga T; Takeda S
Gynecol Oncol; 2013 Jun; 129(3):598-605. PubMed ID: 23500085
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.
Boren T; Xiong Y; Hakam A; Wenham R; Apte S; Wei Z; Kamath S; Chen DT; Dressman H; Lancaster JM
Gynecol Oncol; 2008 Aug; 110(2):206-15. PubMed ID: 18499237
[TBL] [Abstract][Full Text] [Related]
10. Salinomycin reduces epithelial-mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells.
Mao Z; Wu Y; Zhou J; Xing C
Anticancer Drugs; 2019 Oct; 30(9):892-899. PubMed ID: 30882398
[TBL] [Abstract][Full Text] [Related]
11. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.
Fuchs D; Heinold A; Opelz G; Daniel V; Naujokat C
Biochem Biophys Res Commun; 2009 Dec; 390(3):743-9. PubMed ID: 19835841
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment.
Bae J; Won M; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH; Suh DS
Int J Gynecol Cancer; 2012 May; 22(4):561-5. PubMed ID: 22543862
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Wang P; Zeng Z; Shen X; Tian X; Ye Q
DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
[TBL] [Abstract][Full Text] [Related]
14. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
15. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
16. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
17. Changes in the Expression Pattern of DUSP1-7 and miRNA Regulating their Expression in the Keratinocytes Treated with LPS and Adalimumab.
Grabarek BO; Dąbala M; Kasela T; Gralewski M; Gładysz D
Curr Pharm Biotechnol; 2022; 23(6):873-881. PubMed ID: 34342258
[TBL] [Abstract][Full Text] [Related]
18. Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5.
Yu Z; Cheng H; Zhu H; Cao M; Lu C; Bao S; Pan Y; Li Y
Braz J Med Biol Res; 2017 Aug; 50(10):e6147. PubMed ID: 28832761
[TBL] [Abstract][Full Text] [Related]
19. Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics.
Boesch M; Zeimet AG; Rumpold H; Gastl G; Sopper S; Wolf D
Stem Cells Transl Med; 2015 Sep; 4(9):1028-32. PubMed ID: 26136502
[TBL] [Abstract][Full Text] [Related]
20. Salinomycin can effectively kill ALDH(high) stem-like cells on gastric cancer.
Zhi QM; Chen XH; Ji J; Zhang JN; Li JF; Cai Q; Liu BY; Gu QL; Zhu ZG; Yu YY
Biomed Pharmacother; 2011 Oct; 65(7):509-15. PubMed ID: 21996439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
